Lupin Pharmaceuticals Inc. is voluntarily recalling approximately 35,928 bottles of Cefdinir for Oral Suspension USP (250 mg/5mL), an antibiotic used to treat bacterial infections. This recall was initiated after testing of retention samples showed the medication was 'superpotent,' meaning it contains more of the active ingredient than the specification allows. Consumers should contact their healthcare provider or pharmacist regarding this recall and for guidance on their medication. These prescription bottles were distributed nationwide across the United States.
The drug tested as out-of-specification for potency, which could result in patients receiving a higher dose of the antibiotic than intended. While the specific health consequences were not detailed in the report, superpotent medications can increase the risk of side effects or adverse reactions associated with the drug.
Healthcare provider consultation and pharmacy return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.